Pub Date : 2026-02-13eCollection Date: 2026-01-01DOI: 10.47895/amp.vi0.12550
Zen Alfred B Nemenzo, Ma Celina U Garcia
Background and objective: A growing body of evidence points to a positive association between periodontitis and various systemic diseases, including cardiovascular diseases (CVD), hypertension, and rheumatoid arthritis. However, there is limited data on the prevalence and odds of having systemic conditions among Filipino periodontal patients. Thus, this study aimed to determine the association of periodontal disease with systemic conditions among Filipino patients at a university dental clinic.
Methods: The periodontal and medical charts of all patients who underwent periodontal consult at a university dental clinic within two academic years were reviewed. Periodontal diagnoses which had originally been assigned using the 1999 classification of periodontal diseases were reclassified based on the 2018 European Federation of Periodontology-American Academy of Periodontology classification. Listed medical conditions in the patients' charts were self-reported. The prevalence of various systemic conditions in 715 periodontitis cases was compared to that of 834 control patients without periodontitis. Fisher's exact test was performed to evaluate the difference in the prevalence of comorbidities between groups, while adjusted odds ratios (AOR) were computed using logistic regression analysis, accounting for age, sex, educational attainment, and smoking status.
Results: The prevalence of having at least one systemic condition was significantly higher among periodontitis patients (44.5%) compared to non-periodontitis patients (36.3%). Compared to controls, a significantly higher number of periodontitis cases had two systemic comorbidities (P=0.001). The prevalence of hypertension (18.6% versus 5.04%), CVD including hypertension (20.42% versus 6.95%), arthritis (9.37% versus 3.0%), and diabetes mellitus (5.73% versus 0.84%) were all significantly higher in patients with periodontitis compared to non-periodontitis controls. The odds of having CVD (AOR=1.81), hypertension (AOR=2.14) and diabetes (AOR=3.05) were higher in periodontitis cases. Meanwhile, the prevalence of asthma (9.23% versus 5.31%), respiratory diseases including asthma (12.95% versus 8.25%), and allergies (18.82% versus 13.71%) were significantly higher in nonperiodontitis patients compared to periodontitis cases.
Conclusion: Periodontitis patients were more likely to present with CVD, hypertension, and diabetes mellitus. On the other hand, no association was found between periodontitis and respiratory diseases, as well as between periodontitis and asthma.
{"title":"The Association of Periodontal Disease and Systemic Conditions among Filipino Patients in a University Dental Clinic: A Retrospective Case-control Study.","authors":"Zen Alfred B Nemenzo, Ma Celina U Garcia","doi":"10.47895/amp.vi0.12550","DOIUrl":"https://doi.org/10.47895/amp.vi0.12550","url":null,"abstract":"<p><strong>Background and objective: </strong>A growing body of evidence points to a positive association between periodontitis and various systemic diseases, including cardiovascular diseases (CVD), hypertension, and rheumatoid arthritis. However, there is limited data on the prevalence and odds of having systemic conditions among Filipino periodontal patients. Thus, this study aimed to determine the association of periodontal disease with systemic conditions among Filipino patients at a university dental clinic.</p><p><strong>Methods: </strong>The periodontal and medical charts of all patients who underwent periodontal consult at a university dental clinic within two academic years were reviewed. Periodontal diagnoses which had originally been assigned using the 1999 classification of periodontal diseases were reclassified based on the 2018 European Federation of Periodontology-American Academy of Periodontology classification. Listed medical conditions in the patients' charts were self-reported. The prevalence of various systemic conditions in 715 periodontitis cases was compared to that of 834 control patients without periodontitis. Fisher's exact test was performed to evaluate the difference in the prevalence of comorbidities between groups, while adjusted odds ratios (AOR) were computed using logistic regression analysis, accounting for age, sex, educational attainment, and smoking status.</p><p><strong>Results: </strong>The prevalence of having at least one systemic condition was significantly higher among periodontitis patients (44.5%) compared to non-periodontitis patients (36.3%). Compared to controls, a significantly higher number of periodontitis cases had two systemic comorbidities (<i>P</i>=0.001). The prevalence of hypertension (18.6% versus 5.04%), CVD including hypertension (20.42% versus 6.95%), arthritis (9.37% versus 3.0%), and diabetes mellitus (5.73% versus 0.84%) were all significantly higher in patients with periodontitis compared to non-periodontitis controls. The odds of having CVD (AOR=1.81), hypertension (AOR=2.14) and diabetes (AOR=3.05) were higher in periodontitis cases. Meanwhile, the prevalence of asthma (9.23% versus 5.31%), respiratory diseases including asthma (12.95% versus 8.25%), and allergies (18.82% versus 13.71%) were significantly higher in nonperiodontitis patients compared to periodontitis cases.</p><p><strong>Conclusion: </strong>Periodontitis patients were more likely to present with CVD, hypertension, and diabetes mellitus. On the other hand, no association was found between periodontitis and respiratory diseases, as well as between periodontitis and asthma.</p>","PeriodicalId":6994,"journal":{"name":"Acta Medica Philippina","volume":"60 3","pages":"70-77"},"PeriodicalIF":0.0,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12990921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147472224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-13eCollection Date: 2026-01-01DOI: 10.47895/amp.vi0.12703
Mark Andrian O Yano, Angeline Therese Magbitang-Santiago
Gout is the most common inflammatory arthritis among Filipinos, characterized by hyperuricemia leading to monosodium urate crystal deposition and an ensuing inflammatory response. Though typically a disorder of middleaged and older adults, tophaceous gout presenting before the age of 30 is rare and suggests aggressive disease progression. Allopurinol, a first-line urate-lowering therapy, is generally effective but may cause rare, potentially life-threatening adverse reactions such as allopurinol hypersensitivity syndrome (AHS). Febuxostat, a non-purine xanthine oxidase inhibitor, is an alternative for patients intolerant to allopurinol. Although hypersensitivity reactions to febuxostat are extremely rare, isolated case reports document their occurrence in both patients with prior AHS and in allopurinol-naïve individuals. Hypersensitivity to both agents is exceedingly uncommon and presents a major therapeutic challenge. In such cases, febuxostat desensitization, conducted in collaboration with allergy specialists, may permit a viable solution to safely reintroduce urate-lowering therapy and prevent further disease progression. This case report describes a patient with young-onset, tophaceous gout who developed severe hypersensitivity reactions to both allopurinol and febuxostat - an unusual and challenging therapeutic dilemma. The case highlights the need for individualized management strategies, including the consideration of drug desensitization, in patients with limited urate-lowering options.
{"title":"Allopurinol and Febuxostat Hypersensitivity in a Patient with Young Onset Gout: A Case Report.","authors":"Mark Andrian O Yano, Angeline Therese Magbitang-Santiago","doi":"10.47895/amp.vi0.12703","DOIUrl":"https://doi.org/10.47895/amp.vi0.12703","url":null,"abstract":"<p><p>Gout is the most common inflammatory arthritis among Filipinos, characterized by hyperuricemia leading to monosodium urate crystal deposition and an ensuing inflammatory response. Though typically a disorder of middleaged and older adults, tophaceous gout presenting before the age of 30 is rare and suggests aggressive disease progression. Allopurinol, a first-line urate-lowering therapy, is generally effective but may cause rare, potentially life-threatening adverse reactions such as allopurinol hypersensitivity syndrome (AHS). Febuxostat, a non-purine xanthine oxidase inhibitor, is an alternative for patients intolerant to allopurinol. Although hypersensitivity reactions to febuxostat are extremely rare, isolated case reports document their occurrence in both patients with prior AHS and in allopurinol-naïve individuals. Hypersensitivity to both agents is exceedingly uncommon and presents a major therapeutic challenge. In such cases, febuxostat desensitization, conducted in collaboration with allergy specialists, may permit a viable solution to safely reintroduce urate-lowering therapy and prevent further disease progression. This case report describes a patient with young-onset, tophaceous gout who developed severe hypersensitivity reactions to both allopurinol and febuxostat - an unusual and challenging therapeutic dilemma. The case highlights the need for individualized management strategies, including the consideration of drug desensitization, in patients with limited urate-lowering options.</p>","PeriodicalId":6994,"journal":{"name":"Acta Medica Philippina","volume":"60 3","pages":"95-98"},"PeriodicalIF":0.0,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12990925/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147472314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30eCollection Date: 2026-01-01DOI: 10.47895/amp.vi0.11824
Ryan Christopher C Lao, Jessa Louise T Turreda, Monica Angelique O Ramos-Saycon, Ailyn M Yabes
Background and objective: Staphylococcus aureus poses a significant public health threat globally, where both community and hospital-acquired infections are prevalent. The escalating antimicrobial resistance highlights the urgent need for alternative therapies. Hence, traditional medicine using plant extracts offers a potential avenue for novel antibacterial agents. This systematic review aimed to evaluate the existing literature on the antibacterial properties of Philippine plants against S. aureus to provide focus on drug development of a plant-derived antibacterial for this pathogen.
Methods: Following PRISMA guidelines, a comprehensive search was conducted in PubMed/Medline, SCOPUS, and Herdin databases. Inclusion criteria encompassed in vitro studies evaluating the antibacterial activity of crude plant extracts sourced from Philippine plants against S. aureus. Data extraction and quality assessment were performed independently by two reviewers, with discrepancies resolved by the third and fourth reviewers.
Results: Of the 413 initial studies identified, nine met the eligibility criteria. The highest zone of inhibition was demonstrated by Lippia micromera leaf essential oil at 26.3±1.5 mm, while moderate antibacterial activity was shown by essential oils from Alpinia elegans, Piper quinqueangulatum, and Alpinia cumingii at MIC values of 512 μg/mL, 512 μg/mL, and 1,024 μg/mL, respectively. Other Philippine plants showed a wide range of activity, with MIC values between 50 μg/mL and 25 mg/mL, MBC values from 78 to 5000 μg/mL, and ZOI ranging from 5 to 38 mm. However, the overall quality of evidence in these other studies are compromised by bias and incomplete reporting.
Conclusion: Leaf essential oils from Alpinia elegans, Piper quinqueangulatum, and Alpinia cumingii demonstrated moderate antibacterial activity against S. aureus. Additionally, the essential oils of Lippia micromera, Plectranthus amboinicus Lour. Spreng, and Cymbopogon citratus exhibited antibacterial activity against both S. aureus and Methicillin-resistant S. aureus (MRSA) in disk diffusion assays, these antibacterial activities may be attributed to their high concentrations of terpenes, terpenoids, and phenolic compounds. Majority of the studies gathered had high risk of bias according to the quality assessment criteria tool used in the study. Thus, this systematic review also emphasizes the need for improved methodological rigor on reporting in vitro antibacterial studies.
{"title":"A Systematic Review of the Philippine Plants' Antibacterial Properties against <i>Staphylococcus aureus</i>.","authors":"Ryan Christopher C Lao, Jessa Louise T Turreda, Monica Angelique O Ramos-Saycon, Ailyn M Yabes","doi":"10.47895/amp.vi0.11824","DOIUrl":"10.47895/amp.vi0.11824","url":null,"abstract":"<p><strong>Background and objective: </strong><i>Staphylococcus aureus</i> poses a significant public health threat globally, where both community and hospital-acquired infections are prevalent. The escalating antimicrobial resistance highlights the urgent need for alternative therapies. Hence, traditional medicine using plant extracts offers a potential avenue for novel antibacterial agents. This systematic review aimed to evaluate the existing literature on the antibacterial properties of Philippine plants against <i>S. aureus</i> to provide focus on drug development of a plant-derived antibacterial for this pathogen.</p><p><strong>Methods: </strong>Following PRISMA guidelines, a comprehensive search was conducted in PubMed/Medline, SCOPUS, and Herdin databases. Inclusion criteria encompassed <i>in vitro</i> studies evaluating the antibacterial activity of crude plant extracts sourced from Philippine plants against <i>S. aureus</i>. Data extraction and quality assessment were performed independently by two reviewers, with discrepancies resolved by the third and fourth reviewers.</p><p><strong>Results: </strong>Of the 413 initial studies identified, nine met the eligibility criteria. The highest zone of inhibition was demonstrated by <i>Lippia micromera</i> leaf essential oil at 26.3±1.5 mm, while moderate antibacterial activity was shown by essential oils from <i>Alpinia elegans, Piper quinqueangulatum</i>, and <i>Alpinia cumingii</i> at MIC values of 512 μg/mL, 512 μg/mL, and 1,024 μg/mL, respectively. Other Philippine plants showed a wide range of activity, with MIC values between 50 μg/mL and 25 mg/mL, MBC values from 78 to 5000 μg/mL, and ZOI ranging from 5 to 38 mm. However, the overall quality of evidence in these other studies are compromised by bias and incomplete reporting.</p><p><strong>Conclusion: </strong>Leaf essential oils from <i>Alpinia elegans, Piper quinqueangulatum</i>, and <i>Alpinia cumingii</i> demonstrated moderate antibacterial activity against <i>S. aureus</i>. Additionally, the essential oils of <i>Lippia micromera, Plectranthus amboinicus</i> Lour. Spreng, and <i>Cymbopogon citratus</i> exhibited antibacterial activity against both <i>S. aureus</i> and Methicillin-resistant <i>S. aureus</i> (MRSA) in disk diffusion assays, these antibacterial activities may be attributed to their high concentrations of terpenes, terpenoids, and phenolic compounds. Majority of the studies gathered had high risk of bias according to the quality assessment criteria tool used in the study. Thus, this systematic review also emphasizes the need for improved methodological rigor on reporting <i>in vitro</i> antibacterial studies.</p>","PeriodicalId":6994,"journal":{"name":"Acta Medica Philippina","volume":"60 2","pages":"115-123"},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982902/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30eCollection Date: 2026-01-01DOI: 10.47895/amp.vi0.11914
Maria Llaine J Callanta, Karol Ann T Baldo
Objectives: The increasing prevalence of Kawasaki disease in Southeast Asia (SEA) and its potential relation with Coronavirus Disease 2019 (COVID-19) infection resulted in heightened interest in KD in the region, thus, this paper aimed to determine the trend and the socioeconomic facilitators of scientific productivity of KD research within the region. Specifically, this article determined the number of publication and citations related to KD per country, institution, and journal. We also explored the networks of countries within the region to the rest of the world and the keywords mostly associated with KD research in the region. Lastly, correlation of these bibliometric indices with socioeconomic factors in the region was analyzed.
Methods: A literature search of KD papers in SEA was performed using Scopus database. We obtained bibliographic data from the available literature and visualized network of existing collaborations and keywords using VOSviewer software.
Results: A total of 196 papers were included in the study. Bibliometric analysis showed a rising trend in publication within the region, most of which were from institutions in Singapore and Thailand. The most common topics on KD studies included clinical features, complications, treatment, and comorbidities.Country characteristics such as gross domestic product (GDP) per capita, research and development (R&D) expenditure (% GDP), and number of physician and R&D researchers were positively correlated with bibliometric indices of KD research in SEA. Moreover, number of international linkages was significantly associated with KD research productivity in the region.
Conclusion: In summary, we showed an increasing trend of KD research in SEA. Funding allocation and capacity building are necessary to strengthen research productivity within the region.
{"title":"A Bibliometric Analysis of Research Productivity on Kawasaki Disease in Southeast Asia: Trend and Socioeconomic Drivers.","authors":"Maria Llaine J Callanta, Karol Ann T Baldo","doi":"10.47895/amp.vi0.11914","DOIUrl":"10.47895/amp.vi0.11914","url":null,"abstract":"<p><strong>Objectives: </strong>The increasing prevalence of Kawasaki disease in Southeast Asia (SEA) and its potential relation with Coronavirus Disease 2019 (COVID-19) infection resulted in heightened interest in KD in the region, thus, this paper aimed to determine the trend and the socioeconomic facilitators of scientific productivity of KD research within the region. Specifically, this article determined the number of publication and citations related to KD per country, institution, and journal. We also explored the networks of countries within the region to the rest of the world and the keywords mostly associated with KD research in the region. Lastly, correlation of these bibliometric indices with socioeconomic factors in the region was analyzed.</p><p><strong>Methods: </strong>A literature search of KD papers in SEA was performed using Scopus database. We obtained bibliographic data from the available literature and visualized network of existing collaborations and keywords using VOSviewer software.</p><p><strong>Results: </strong>A total of 196 papers were included in the study. Bibliometric analysis showed a rising trend in publication within the region, most of which were from institutions in Singapore and Thailand. The most common topics on KD studies included clinical features, complications, treatment, and comorbidities.Country characteristics such as gross domestic product (GDP) per capita, research and development (R&D) expenditure (% GDP), and number of physician and R&D researchers were positively correlated with bibliometric indices of KD research in SEA. Moreover, number of international linkages was significantly associated with KD research productivity in the region.</p><p><strong>Conclusion: </strong>In summary, we showed an increasing trend of KD research in SEA. Funding allocation and capacity building are necessary to strengthen research productivity within the region.</p>","PeriodicalId":6994,"journal":{"name":"Acta Medica Philippina","volume":"60 2","pages":"33-40"},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982905/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30eCollection Date: 2026-01-01DOI: 10.47895/amp.vi0.11821
Junel F Fiestada, Mary Ann J Ladia
Background and objective: Humans need constant interaction for a better well-being. It is advisable to actively participate socially to acquire psychological support and elicit satisfaction. In fact, social participation is a key driver of life satisfaction among the elderly. This study aims to describe social participation and life satisfaction among employees of a premier university in Manila, Philippines and infer their relationship through activity theory.
Methods: Seventy-one participants ages fifty years and older as of June 30, 2020 representing various employee categories participated in the online survey: a) faculty; b) research extension and professional staff; and c) administrative staff. Ten key informant interviews (KIIs) were likewise conducted to determine their opinions and perceptions on social participation in campus.
Results: Social media usage and "malling" ranked the highest, contributing to 76% and 48% of the activities for indoor and outdoor activities, respectively. In terms of membership, professional organizations comprised 69%. On the other hand, 68% of organization members were elected officers. The relationship between social participation and life satisfaction were observable as indicated by the high rate of social participation and low percentage of participants who reported life dissatisfaction (4%).
Conclusions: High levels of social participation in terms of indoor and outdoor activities; membership including activeness in organizations; as well as positions held in organizations may indicate high levels of life satisfaction. Further research on a large sample size may explore statistical analysis on the longitudinal effects of social participation and life satisfaction.
{"title":"Social Participation and Life Satisfaction of Employees in the Academe using Online Survey and Key Informant Interview.","authors":"Junel F Fiestada, Mary Ann J Ladia","doi":"10.47895/amp.vi0.11821","DOIUrl":"10.47895/amp.vi0.11821","url":null,"abstract":"<p><strong>Background and objective: </strong>Humans need constant interaction for a better well-being. It is advisable to actively participate socially to acquire psychological support and elicit satisfaction. In fact, social participation is a key driver of life satisfaction among the elderly. This study aims to describe social participation and life satisfaction among employees of a premier university in Manila, Philippines and infer their relationship through activity theory.</p><p><strong>Methods: </strong>Seventy-one participants ages fifty years and older as of June 30, 2020 representing various employee categories participated in the online survey: a) faculty; b) research extension and professional staff; and c) administrative staff. Ten key informant interviews (KIIs) were likewise conducted to determine their opinions and perceptions on social participation in campus.</p><p><strong>Results: </strong>Social media usage and \"malling\" ranked the highest, contributing to 76% and 48% of the activities for indoor and outdoor activities, respectively. In terms of membership, professional organizations comprised 69%. On the other hand, 68% of organization members were elected officers. The relationship between social participation and life satisfaction were observable as indicated by the high rate of social participation and low percentage of participants who reported life dissatisfaction (4%).</p><p><strong>Conclusions: </strong>High levels of social participation in terms of indoor and outdoor activities; membership including activeness in organizations; as well as positions held in organizations may indicate high levels of life satisfaction. Further research on a large sample size may explore statistical analysis on the longitudinal effects of social participation and life satisfaction.</p>","PeriodicalId":6994,"journal":{"name":"Acta Medica Philippina","volume":"60 2","pages":"66-72"},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982903/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30eCollection Date: 2026-01-01DOI: 10.47895/amp.vi0.9991
Elizabeth Paz-Pacheco, Angelique Bea C Uy, Angelique Love Tiglao-Gica, Anna Elvira S Arcellana, Aura Bree Dayo-Lacdao, Cynthia P Cordero, Cecilia A Jimeno, Ma Cecille Añonuevo-Cruz, Noel R Juban
<p><strong>Background and objective: </strong>In Asia, younger individuals (below age 45) are diagnosed to have type 2 diabetes with increased rates of obesity defined by lower BMI yet with greater visceral adiposity (waist circumference and waisthip ratios). The prevalence data on type 1 diabetes is not well established, considered to be low, but is seen to be increasing as well. This changing phenotype therefore, presents a clinical dilemma in terms of correctly classifying diabetes and deciding on the consequent appropriate treatment. Distinguishing type 1 from type 2 diabetes has become more difficult with type 2 diabetes dramatically increasing in young adults and children. This study aims to define the characteristics of diabetes among young adults in the Philippines to provide a basis for appropriate management amidst changes in diabetes phenotypes seen globally.</p><p><strong>Methods: </strong>In this cross-sectional analytic study, we characterized the demographic, metabolic, and autoimmune features of diabetes among young adult Filipinos aged 18 to 45 years old consulting at a tertiary referral center in Manila, Philippines. Baseline serum A1c, FBS, 75-g oral glucose tolerance test, insulin, serum C-peptide, insulin autoantibodies, leptin, adiponectin, lipid profile, and thyroid function tests were obtained from the participants and analyzed. The homeostasis model assessment (HOMA) was used to estimate the insulin sensitivity.</p><p><strong>Results: </strong>A total of 348 patients with diabetes were included, with females comprising two-thirds of the participants. The mean age at diagnosis of diabetes was 35.9±7.22 years. The mean BMI was 28.12 kg/m<sup>2</sup>, with median waist to hip ratio (WHR) of 0·93. Metabolic syndrome was found in 60% of participants and 67.82% were obese by body mass index. The mean A1c was 9.07±2.52%. Good glucose control (A1c less than 7.0%) was seen in 23% of participants while nearly half (48%) had HbA1c which was >9.0%. The median levels of fasting insulin and C-peptide were 12.62 (range 1.33-90.42) mIU/L and 0.78 ng/mL (range 0-16.2), respectively.Included participants were diagnosed with diabetes within a year and as such, majority did not have any micro- or macrovascular complications. The most common diabetes complication was sensory neuropathy detected by monofilament testing, which was found in 28% of participants, followed by non-proliferative diabetic retinopathy in 13%. A history of previous diabetic ketoacidosis was found in 10 patients (2.87%). Glutamic acid decarboxylase (GAD) and insulin auto-antibodies were found in 3.2% and 19.3% of participants, respectively. Approximately half (51.73%) of the participants were insulin resistant by HOMA-IR.</p><p><strong>Conclusion: </strong>In contrast with Caucasians and other Asians, diabetes among young Filipino adults is associated with lower BMI but with a similarly high visceral adiposity as shown by an elevated WHR. Metabolic syndrome with insulin
{"title":"Clinical, Metabolic, and Autoimmune Characteristics of Newly Diagnosed Young Filipino Adults with Diabetes Mellitus.","authors":"Elizabeth Paz-Pacheco, Angelique Bea C Uy, Angelique Love Tiglao-Gica, Anna Elvira S Arcellana, Aura Bree Dayo-Lacdao, Cynthia P Cordero, Cecilia A Jimeno, Ma Cecille Añonuevo-Cruz, Noel R Juban","doi":"10.47895/amp.vi0.9991","DOIUrl":"10.47895/amp.vi0.9991","url":null,"abstract":"<p><strong>Background and objective: </strong>In Asia, younger individuals (below age 45) are diagnosed to have type 2 diabetes with increased rates of obesity defined by lower BMI yet with greater visceral adiposity (waist circumference and waisthip ratios). The prevalence data on type 1 diabetes is not well established, considered to be low, but is seen to be increasing as well. This changing phenotype therefore, presents a clinical dilemma in terms of correctly classifying diabetes and deciding on the consequent appropriate treatment. Distinguishing type 1 from type 2 diabetes has become more difficult with type 2 diabetes dramatically increasing in young adults and children. This study aims to define the characteristics of diabetes among young adults in the Philippines to provide a basis for appropriate management amidst changes in diabetes phenotypes seen globally.</p><p><strong>Methods: </strong>In this cross-sectional analytic study, we characterized the demographic, metabolic, and autoimmune features of diabetes among young adult Filipinos aged 18 to 45 years old consulting at a tertiary referral center in Manila, Philippines. Baseline serum A1c, FBS, 75-g oral glucose tolerance test, insulin, serum C-peptide, insulin autoantibodies, leptin, adiponectin, lipid profile, and thyroid function tests were obtained from the participants and analyzed. The homeostasis model assessment (HOMA) was used to estimate the insulin sensitivity.</p><p><strong>Results: </strong>A total of 348 patients with diabetes were included, with females comprising two-thirds of the participants. The mean age at diagnosis of diabetes was 35.9±7.22 years. The mean BMI was 28.12 kg/m<sup>2</sup>, with median waist to hip ratio (WHR) of 0·93. Metabolic syndrome was found in 60% of participants and 67.82% were obese by body mass index. The mean A1c was 9.07±2.52%. Good glucose control (A1c less than 7.0%) was seen in 23% of participants while nearly half (48%) had HbA1c which was >9.0%. The median levels of fasting insulin and C-peptide were 12.62 (range 1.33-90.42) mIU/L and 0.78 ng/mL (range 0-16.2), respectively.Included participants were diagnosed with diabetes within a year and as such, majority did not have any micro- or macrovascular complications. The most common diabetes complication was sensory neuropathy detected by monofilament testing, which was found in 28% of participants, followed by non-proliferative diabetic retinopathy in 13%. A history of previous diabetic ketoacidosis was found in 10 patients (2.87%). Glutamic acid decarboxylase (GAD) and insulin auto-antibodies were found in 3.2% and 19.3% of participants, respectively. Approximately half (51.73%) of the participants were insulin resistant by HOMA-IR.</p><p><strong>Conclusion: </strong>In contrast with Caucasians and other Asians, diabetes among young Filipino adults is associated with lower BMI but with a similarly high visceral adiposity as shown by an elevated WHR. Metabolic syndrome with insulin ","PeriodicalId":6994,"journal":{"name":"Acta Medica Philippina","volume":"60 2","pages":"41-49"},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982899/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30eCollection Date: 2026-01-01DOI: 10.47895/amp.vi0.10597
Camille Francesca T Cadag, Althea B Lorenzo, Justine Marie M Mercado, Frances Lois U Ngo
Background and objectives: Non-Hodgkin Lymphoma (NHL) ranks 11th in cancer incidence and mortality in the Philippines with the combination chemotherapy composed of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) being commonly used as treatment. However, the addition of Rituximab to CHOP (R-CHOP) has been shown to exhibit higher response rates and longer remissions, potentially improving quality of life. Currently, there is conflicting evidence on the cost-utility of CHOP versus R-CHOP. The study aimed to describe the patient-and country-specific factors, and treatment modalities used for NHL and systematically review cost-utility evidence of R-CHOP versus CHOP in adult NHL patients.
Methods: A systematic literature search of cost-utility studies on R-CHOP versus CHOP for NHL treatment was performed on eight databases: PubMed/MEDLINE, Scopus, Web of Science, EBSCOHost, Cochrane, York Research Database, Centre for Reviews and Dissemination Database, and HERDIN, where 607 studies were identified. Upon screening using an eligibility criteria, 10 studies were included and critically assessed using four appraisal tools: CHEERS, Drummond, Cooper, and ECOBIAS. These were performed independently by two authors with a third author assisting to help reach a consensus.
Results: All studies from high-income countries (HICs) (n=8) and low-middle-income country (LMIC) (n=1) suggested that R-CHOP was more cost-effective for NHL treatment than CHOP in terms of utility outcomes. The study conducted in a low-income country (LIC) (n=1) suggested the opposite, favoring CHOP over R-CHOP. Methodological differences such as perspective, discount rate, willingness-to-pay (WTP), time horizon, and economic model were observed. Methodological limitations include completeness of data reported and credibility of sources used.
Conclusion: The results of this review shall be interpreted with caution as those favoring R-CHOP over CHOP for NHL treatment in terms of cost-utility were concentrated in HICs. More economic evaluations from LICs, LMICs, and upper-middle income countries (UMICs) are needed for a robust conclusion. Additionally, establishing a universally recognized guideline for economic evaluations is essential to guide researchers effectively.
背景与目的:非霍奇金淋巴瘤(NHL)在菲律宾癌症发病率和死亡率中排名第11位,常用环磷酰胺、阿霉素、长春新碱、强的松联合化疗(CHOP)治疗。然而,在CHOP (R-CHOP)中加入利妥昔单抗已显示出更高的缓解率和更长的缓解期,可能改善生活质量。目前,关于CHOP与R-CHOP的成本-效用存在矛盾的证据。该研究旨在描述NHL患者和国家的特定因素,以及用于NHL的治疗方式,并系统地回顾成人NHL患者R-CHOP与CHOP的成本-效用证据。方法:在PubMed/MEDLINE、Scopus、Web of Science、EBSCOHost、Cochrane、York Research Database、Centre for Reviews and Dissemination Database和HERDIN等8个数据库中对R-CHOP与CHOP治疗NHL的成本-效益研究进行系统文献检索,共发现607项研究。在使用资格标准进行筛选后,纳入了10项研究,并使用四种评估工具进行了严格评估:CHEERS、Drummond、Cooper和ECOBIAS。这些由两位作者独立完成,第三位作者协助达成共识。结果:来自高收入国家(HICs) (n=8)和中低收入国家(LMIC) (n=1)的所有研究都表明,就效用结果而言,R-CHOP比CHOP治疗NHL更具成本效益。在低收入国家(LIC) (n=1)进行的研究表明,相反,倾向于CHOP而不是R-CHOP。方法上的差异,如视角、贴现率、支付意愿(WTP)、时间范围和经济模型。方法学的局限性包括报告数据的完整性和所用来源的可信度。结论:本综述的结果应谨慎解读,因为在成本-效用方面,支持R-CHOP而非CHOP治疗NHL的研究集中在HICs中。需要对低收入国家、中低收入国家和中高收入国家(UMICs)进行更多的经济评估,才能得出强有力的结论。此外,建立一个普遍认可的经济评价准则对于有效地指导研究人员至关重要。
{"title":"Cost-utility Analysis of R-CHOP vs CHOP in Patients with Non-Hodgkin's Lymphoma: A Systematic Review.","authors":"Camille Francesca T Cadag, Althea B Lorenzo, Justine Marie M Mercado, Frances Lois U Ngo","doi":"10.47895/amp.vi0.10597","DOIUrl":"10.47895/amp.vi0.10597","url":null,"abstract":"<p><strong>Background and objectives: </strong>Non-Hodgkin Lymphoma (NHL) ranks 11th in cancer incidence and mortality in the Philippines with the combination chemotherapy composed of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) being commonly used as treatment. However, the addition of Rituximab to CHOP (R-CHOP) has been shown to exhibit higher response rates and longer remissions, potentially improving quality of life. Currently, there is conflicting evidence on the cost-utility of CHOP versus R-CHOP. The study aimed to describe the patient-and country-specific factors, and treatment modalities used for NHL and systematically review cost-utility evidence of R-CHOP versus CHOP in adult NHL patients.</p><p><strong>Methods: </strong>A systematic literature search of cost-utility studies on R-CHOP versus CHOP for NHL treatment was performed on eight databases: PubMed/MEDLINE, Scopus, Web of Science, EBSCOHost, Cochrane, York Research Database, Centre for Reviews and Dissemination Database, and HERDIN, where 607 studies were identified. Upon screening using an eligibility criteria, 10 studies were included and critically assessed using four appraisal tools: CHEERS, Drummond, Cooper, and ECOBIAS. These were performed independently by two authors with a third author assisting to help reach a consensus.</p><p><strong>Results: </strong>All studies from high-income countries (HICs) (n=8) and low-middle-income country (LMIC) (n=1) suggested that R-CHOP was more cost-effective for NHL treatment than CHOP in terms of utility outcomes. The study conducted in a low-income country (LIC) (n=1) suggested the opposite, favoring CHOP over R-CHOP. Methodological differences such as perspective, discount rate, willingness-to-pay (WTP), time horizon, and economic model were observed. Methodological limitations include completeness of data reported and credibility of sources used.</p><p><strong>Conclusion: </strong>The results of this review shall be interpreted with caution as those favoring R-CHOP over CHOP for NHL treatment in terms of cost-utility were concentrated in HICs. More economic evaluations from LICs, LMICs, and upper-middle income countries (UMICs) are needed for a robust conclusion. Additionally, establishing a universally recognized guideline for economic evaluations is essential to guide researchers effectively.</p>","PeriodicalId":6994,"journal":{"name":"Acta Medica Philippina","volume":"60 2","pages":"84-114"},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982907/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30eCollection Date: 2026-01-01DOI: 10.47895/amp.vi0.12478
Martina Therese R Reyes, Maria Regina Justina E Estuar, Jann Railey E Montalan
Background and objective: Access to healthcare remains a challenge in most areas in the Philippines. Fifty-three percent (53%) of the Philippine population do not have access to a rural health unit (RHU) within a 30-minute travel time. As a response, the Department of Health (DOH) needs to construct an additional 2400 RHUs by 2025. This paper uses the Philippine Health Facility Development Plan 2020-2040 (PHFDP) as a reference to present a solution for locating sites for RHU placement in under-served areas using neural networks to meet the 30-minute travel time by maximizing population accessibility.
Methods: RHU accessibility was measured using geographic attributes as inputs to a back propagation neural network (BPNN) and a recurrent neural network (RNN): (1) land coverage and hazard data, representing geographical limitations; (2) population density and distribution, indicating demand for healthcare services; and (3) infrastructure-related features, such as road networks, points of interest, and the locations of existing RHUs, which influence healthcare accessibility. The models were trained to identify underserved areas and were implemented on a nationwide scale, excluding NCR, to locate candidate areas to increase population access to the new RHUs. The models were validated using a healthcare facility accessibility index (HCFAI) to assess RHU coverage improvement.
Results: The BPNN showed stronger generalization across regions, achieving 79.1% average accuracy in distinguishing low from high accessible areas on Region 1 and identifying 1668 out of 3305 locations in the region as candidate sites. The RNN, better capturing unique regional characteristics, required separate training: 77.2% average accuracy on Region 1, identifying 1593 candidate sites. Our findings suggest expanding the use of land improves population access to healthcare facilities. Both models found more than the needed number of RHUs by 2040. The BPNN was more consistent than RNN to improve a region's overall accessibility by increasing the HCFAI. The BPNN can increase population access to an RHU from 2.5-98.5% from its original population with access to an RHU.
Conclusion: The study demonstrates the usage of geographic attributes and neural networks to improve healthcare accessibility. The BPNN and RNN are adequate algorithms to find under-served areas and candidate sites for RHU construction to maximize population accessibility. The HCFAI metric validates the locations to highlight which neural network maximizes more of the region's population. The study contributes to ongoing efforts to improve healthcare infrastructure and accessibility, offering data-driven recommendations for RHU locations.
{"title":"Providing Universal Health Care Access to Filipinos Region-wide using Back Propagation and Recurrent Neural Networks for Finding Optimal Locations to Place Rural Health Unit Facilities in the Philippines.","authors":"Martina Therese R Reyes, Maria Regina Justina E Estuar, Jann Railey E Montalan","doi":"10.47895/amp.vi0.12478","DOIUrl":"10.47895/amp.vi0.12478","url":null,"abstract":"<p><strong>Background and objective: </strong>Access to healthcare remains a challenge in most areas in the Philippines. Fifty-three percent (53%) of the Philippine population do not have access to a rural health unit (RHU) within a 30-minute travel time. As a response, the Department of Health (DOH) needs to construct an additional 2400 RHUs by 2025. This paper uses the Philippine Health Facility Development Plan 2020-2040 (PHFDP) as a reference to present a solution for locating sites for RHU placement in under-served areas using neural networks to meet the 30-minute travel time by maximizing population accessibility.</p><p><strong>Methods: </strong>RHU accessibility was measured using geographic attributes as inputs to a back propagation neural network (BPNN) and a recurrent neural network (RNN): (1) land coverage and hazard data, representing geographical limitations; (2) population density and distribution, indicating demand for healthcare services; and (3) infrastructure-related features, such as road networks, points of interest, and the locations of existing RHUs, which influence healthcare accessibility. The models were trained to identify underserved areas and were implemented on a nationwide scale, excluding NCR, to locate candidate areas to increase population access to the new RHUs. The models were validated using a healthcare facility accessibility index (HCFAI) to assess RHU coverage improvement.</p><p><strong>Results: </strong>The BPNN showed stronger generalization across regions, achieving 79.1% average accuracy in distinguishing low from high accessible areas on Region 1 and identifying 1668 out of 3305 locations in the region as candidate sites. The RNN, better capturing unique regional characteristics, required separate training: 77.2% average accuracy on Region 1, identifying 1593 candidate sites. Our findings suggest expanding the use of land improves population access to healthcare facilities. Both models found more than the needed number of RHUs by 2040. The BPNN was more consistent than RNN to improve a region's overall accessibility by increasing the HCFAI. The BPNN can increase population access to an RHU from 2.5-98.5% from its original population with access to an RHU.</p><p><strong>Conclusion: </strong>The study demonstrates the usage of geographic attributes and neural networks to improve healthcare accessibility. The BPNN and RNN are adequate algorithms to find under-served areas and candidate sites for RHU construction to maximize population accessibility. The HCFAI metric validates the locations to highlight which neural network maximizes more of the region's population. The study contributes to ongoing efforts to improve healthcare infrastructure and accessibility, offering data-driven recommendations for RHU locations.</p>","PeriodicalId":6994,"journal":{"name":"Acta Medica Philippina","volume":"60 2","pages":"7-14"},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982904/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30eCollection Date: 2026-01-01DOI: 10.47895/amp.vi0.10375
Zsarie P Buenavidez, Althea Kathleen P Brum, Krizia Marie T Manzo, Zenia Luisa M Mora, Perlita M Crucis, April Mergelle R Lapuz, Kevin Jace A Miranda, Rogie Royce Z Carandang
<p><strong>Background and objectives: </strong>The <i>in vitro</i> bioequivalence assessment using a dissolution apparatus, as specified by the United States Pharmacopeia (USP), is a critical parameter in the formulation and development of generic pharmaceutical products. This study is crucial for evaluating the interchangeability of generic drugs with their reference innovator counterparts. Post-market surveillance of generic drugs ensures consistent quality after distribution in the market. Metformin hydrochloride, a widely prescribed oral hypoglycemic agent for managing type 2 diabetes, is among the most utilized medications globally.In the Philippines, there is a growing need to assess the bioequivalence of various generic formulations of metformin HCl film coated tablets to ensure compliance with regulatory requirements. The Philippine Food and Drug Administration (FDA) mandates <i>in vivo</i> or <i>in vitro</i> bioequivalence including, dissolution profile comparison, as a prerequisite for the registration of generic drugs. This study aims to evaluate the quality and <i>in vitro</i> bioequivalence of metformin HCl film-coated tablets available in the Philippine market by comparing their dissolution profiles against the innovator, Glucophage. This research seeks to provide insights into the interchangeability, therapeutic equivalence, and overall quality of these generic formulations, thus contributing to public health and regulatory standards.</p><p><strong>Methods: </strong>Generic metformin HCl film-coated tablets were subjected to quality control tests, including weight variation, thickness and diameter, hardness, friability, and disintegration tests, in accordance with USP guidelines. To assess <i>in vitro</i> bioequivalence, dissolution testing was performed, and the concentration of the dissolved drug was determined using a microplate assay reader to measure absorbance. Dissolution profiles of the generic metformin HCl film-coated tablets were compared to that of the innovator drug, Glucophage to evaluate bioequivalence.</p><p><strong>Results: </strong>All tested generic metformin HCl film-coated tablets complied with USP specifications for quality control tests, except for the hardness test, where three brands failed to meet the required standards. While for dissolution testing, five out of six generic brands demonstrated acceptable dissolution profiles and were bioequivalent to the innovator drug Glucophage. However, one brand (Brand A) failed to meet the bioequivalence criteria, exhibiting a dissolution profile outside the acceptable limits.</p><p><strong>Conclusion: </strong>This study demonstrates that most generic metformin HCl film-coated tablets available in the Philippine market meet the United States Pharmacopeia (USP) quality control requirements and exhibit <i>in vitro</i> bioequivalence with the innovator drug. However, the failure of three brands to meet the hardness specifications and the lack of bioequivalence in one b
{"title":"<i>In vitro</i> Bioequivalence Analysis of Generic Metformin Hydrochloride Film-coated Tablets.","authors":"Zsarie P Buenavidez, Althea Kathleen P Brum, Krizia Marie T Manzo, Zenia Luisa M Mora, Perlita M Crucis, April Mergelle R Lapuz, Kevin Jace A Miranda, Rogie Royce Z Carandang","doi":"10.47895/amp.vi0.10375","DOIUrl":"10.47895/amp.vi0.10375","url":null,"abstract":"<p><strong>Background and objectives: </strong>The <i>in vitro</i> bioequivalence assessment using a dissolution apparatus, as specified by the United States Pharmacopeia (USP), is a critical parameter in the formulation and development of generic pharmaceutical products. This study is crucial for evaluating the interchangeability of generic drugs with their reference innovator counterparts. Post-market surveillance of generic drugs ensures consistent quality after distribution in the market. Metformin hydrochloride, a widely prescribed oral hypoglycemic agent for managing type 2 diabetes, is among the most utilized medications globally.In the Philippines, there is a growing need to assess the bioequivalence of various generic formulations of metformin HCl film coated tablets to ensure compliance with regulatory requirements. The Philippine Food and Drug Administration (FDA) mandates <i>in vivo</i> or <i>in vitro</i> bioequivalence including, dissolution profile comparison, as a prerequisite for the registration of generic drugs. This study aims to evaluate the quality and <i>in vitro</i> bioequivalence of metformin HCl film-coated tablets available in the Philippine market by comparing their dissolution profiles against the innovator, Glucophage. This research seeks to provide insights into the interchangeability, therapeutic equivalence, and overall quality of these generic formulations, thus contributing to public health and regulatory standards.</p><p><strong>Methods: </strong>Generic metformin HCl film-coated tablets were subjected to quality control tests, including weight variation, thickness and diameter, hardness, friability, and disintegration tests, in accordance with USP guidelines. To assess <i>in vitro</i> bioequivalence, dissolution testing was performed, and the concentration of the dissolved drug was determined using a microplate assay reader to measure absorbance. Dissolution profiles of the generic metformin HCl film-coated tablets were compared to that of the innovator drug, Glucophage to evaluate bioequivalence.</p><p><strong>Results: </strong>All tested generic metformin HCl film-coated tablets complied with USP specifications for quality control tests, except for the hardness test, where three brands failed to meet the required standards. While for dissolution testing, five out of six generic brands demonstrated acceptable dissolution profiles and were bioequivalent to the innovator drug Glucophage. However, one brand (Brand A) failed to meet the bioequivalence criteria, exhibiting a dissolution profile outside the acceptable limits.</p><p><strong>Conclusion: </strong>This study demonstrates that most generic metformin HCl film-coated tablets available in the Philippine market meet the United States Pharmacopeia (USP) quality control requirements and exhibit <i>in vitro</i> bioequivalence with the innovator drug. However, the failure of three brands to meet the hardness specifications and the lack of bioequivalence in one b","PeriodicalId":6994,"journal":{"name":"Acta Medica Philippina","volume":"60 2","pages":"50-58"},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982900/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30eCollection Date: 2026-01-01DOI: 10.47895/amp.vi0.11548
Mark John D Sabando, Felix Eduardo R Punzalan, Frances Dominique V Ho, Tam Adrian P Aya-Ay, Kevin Paul DA Enriquez, Marie Kirk A Maramara, Ronald Allan B Roderos, Lauren Kay M Evangelista
Background and objectives: Clinical pathways (CPs) ensure adherence to heart failure (HF) management guidelines. To optimize quality care in a low resource setting, an evidence-based care pathway for the management of acute HF was implemented at the emergency department (ED) of the Philippine General Hospital (PGH), the designated national tertiary hospital and referral center. This study aimed to describe the characteristics of adults with acute HF admitted at the ED and evaluate the quality of care they received, measured using physician adherence to the hospital's acute heart failure CP.
Methods: This was a retrospective, descriptive cohort study. We reviewed the inpatient charts of all adult patients with acute HF admitted to the ED of the PGH and referred to the Division of Cardiovascular Medicine between December 1, 2022 and May 31, 2023. Quality of care was assessed based on adherence to quality indicators adapted from routine and conditional order sets detailed in the pathway. Descriptive statistics was utilized to describe patient characteristics, quality of care, and outcomes.
Results: Two hundred thirty-six (236) patients were included, with a mean age of 51.8 years. Majority were male (53.4%); hypertension (61.4%) and ischemic heart disease (53.8%) were the most common comorbidities, and infection the most common precipitant of decompensation (60.6%). There were optimal adherence rates to routine orders, which included referrals to Internal Medicine and Cardiology, baseline vital signs monitoring, fluid intake and output monitoring, chest radiograph, complete blood count, blood urea nitrogen, sodium, potassium, prothrombin time, partial thromboplastin time, arterial blood gas, urinalysis, and N-terminal pro b-type natriuretic peptide. Conditional orders, such as oxygen support, focused echocardiography, thyroid-stimulating hormone, and the use of vasopressors, diuretics, and venous thromboembolism prophylactic agents, were optimally performed when warranted. However, we noted suboptimal adherence to certain resource-intensive conditional orders, such as hourly monitoring of urine output (61.4%), hooking to cardiac monitor (53.8%), and performance of 12-lead ECG within 10 minutes (56.8%). Further, only 43.9% of patients were referred to the intensive care unit. Troponin I, calcium, magnesium, and albumin were ordered in excess.
Conclusion: Overall adherence rate of physicians to the hospital's Acute Heart Failure Pathway was satisfactory. Work is needed to improve adherence to hourly urine output monitoring, consistent hooking to cardiac monitor, and timely performance of 12-lead ECG - an effort that begins with expanding in-hospital diagnostic equipment and human resource supply. We recommend continuous pathway implementation with periodic evaluation and stakeholder feedback to further improve quality of care.
{"title":"Quality of Care among Patients with Acute Heart Failure at the Emergency Room and Adherence of Physicians at the University of the Philippines - Philippine General Hospital to the Division of Cardiovascular Medicine - Heart Failure Pathway: A Retrospective Cohort Study.","authors":"Mark John D Sabando, Felix Eduardo R Punzalan, Frances Dominique V Ho, Tam Adrian P Aya-Ay, Kevin Paul DA Enriquez, Marie Kirk A Maramara, Ronald Allan B Roderos, Lauren Kay M Evangelista","doi":"10.47895/amp.vi0.11548","DOIUrl":"10.47895/amp.vi0.11548","url":null,"abstract":"<p><strong>Background and objectives: </strong>Clinical pathways (CPs) ensure adherence to heart failure (HF) management guidelines. To optimize quality care in a low resource setting, an evidence-based care pathway for the management of acute HF was implemented at the emergency department (ED) of the Philippine General Hospital (PGH), the designated national tertiary hospital and referral center. This study aimed to describe the characteristics of adults with acute HF admitted at the ED and evaluate the quality of care they received, measured using physician adherence to the hospital's acute heart failure CP.</p><p><strong>Methods: </strong>This was a retrospective, descriptive cohort study. We reviewed the inpatient charts of all adult patients with acute HF admitted to the ED of the PGH and referred to the Division of Cardiovascular Medicine between December 1, 2022 and May 31, 2023. Quality of care was assessed based on adherence to quality indicators adapted from routine and conditional order sets detailed in the pathway. Descriptive statistics was utilized to describe patient characteristics, quality of care, and outcomes.</p><p><strong>Results: </strong>Two hundred thirty-six (236) patients were included, with a mean age of 51.8 years. Majority were male (53.4%); hypertension (61.4%) and ischemic heart disease (53.8%) were the most common comorbidities, and infection the most common precipitant of decompensation (60.6%). There were optimal adherence rates to routine orders, which included referrals to Internal Medicine and Cardiology, baseline vital signs monitoring, fluid intake and output monitoring, chest radiograph, complete blood count, blood urea nitrogen, sodium, potassium, prothrombin time, partial thromboplastin time, arterial blood gas, urinalysis, and N-terminal pro b-type natriuretic peptide. Conditional orders, such as oxygen support, focused echocardiography, thyroid-stimulating hormone, and the use of vasopressors, diuretics, and venous thromboembolism prophylactic agents, were optimally performed when warranted. However, we noted suboptimal adherence to certain resource-intensive conditional orders, such as hourly monitoring of urine output (61.4%), hooking to cardiac monitor (53.8%), and performance of 12-lead ECG within 10 minutes (56.8%). Further, only 43.9% of patients were referred to the intensive care unit. Troponin I, calcium, magnesium, and albumin were ordered in excess.</p><p><strong>Conclusion: </strong>Overall adherence rate of physicians to the hospital's Acute Heart Failure Pathway was satisfactory. Work is needed to improve adherence to hourly urine output monitoring, consistent hooking to cardiac monitor, and timely performance of 12-lead ECG - an effort that begins with expanding in-hospital diagnostic equipment and human resource supply. We recommend continuous pathway implementation with periodic evaluation and stakeholder feedback to further improve quality of care.</p>","PeriodicalId":6994,"journal":{"name":"Acta Medica Philippina","volume":"60 2","pages":"22-32"},"PeriodicalIF":0.0,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12982906/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147462524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}